β-alanine in the Treatment of Advanced Hepatocellular Carcinoma

NCT07317414 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

158

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Atezolizumab combined with bevacizumab combined with β- alanine
DRUG: Atezolizumab combined with bevacizumab

Sponsor

Peking Union Medical College Hospital